Methylphenidate and the hyperkinetic state.
D001259:Ataxia / Q000139:chemically induced; D002648:Child; D004357:Drug Synergism; D001068:Feeding and Eating Disorders / Q000139:chemically induced; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy*; D006973:Hypertension / Q000139:chemically induced; D008774:Methylphenidate / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D010672:Phenytoin / Q000627:therapeutic use; D011600:Psychopharmacology; D012154:Reticular Formation / Q000187:drug effects; D013064:Speech Disorders / Q000188:drug therapy; D019966:Substance-Related Disorders; D013610:Tachycardia / Q000139:chemically induced
D008774:Methylphenidate; D010672:Phenytoin